Nifty
Sensex
:
:
24342.15
80006.93
-167.10 (-0.68%)
-495.15 (-0.62%)

Pharmaceuticals & Drugs

Rating :
39/99

BSE: 506919 | NSE: Not Listed

135.15
22-Jul-2024
  • Open
  • High
  • Low
  • Previous Close
  •  129.8
  •  137
  •  127.05
  •  127.60
  • Volume
  • Traded Value (lacs)
  • 52 Week High
  • 52 Week Low
  •  6482
  •  862736
  •  157.00
  •  98.05

Stock Summary

  • Market Cap(Crs)
  • Stock P:E
  • Face Value
  • 79.74
  • N/A
  • 10
  • Enterprise Value(Crs)
  • Dividend Yield
  • Price:Book Value
  • 95.21
  • N/A
  • 1.26

Shareholding Pattern

  • Promoter
  • Corporate
  • Public
  • 61.27%
  • 2.49%
  • 30.55%
  • FII
  • DII
  • Others
  • 0%
  • 0.00%
  • 5.69%

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • -2.75
  • -0.92
  • -6.38

EBITDA CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • -
  • -
  • -43.14

PAT CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • -
  • 125.20
  • -

P:E (Median)

  • 8 Years
  • 5 Years
  • 3 Years
  • -
  • -
  • -

P:BV (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • 1.18
  • 1.26
  • 1.26

EV:EBITDA (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • 13.15
  • 14.07
  • 14.07

Quarterly Results

Consolidated Figures in Rs. Crores /

Standalone
Description
Mar 24
Mar 23
Var%
Dec 23
Dec 22
Var%
Sep 23
Sep 22
Var%
Jun 23
Jun 22
Var%
Net Sales
27.81
29.45
-5.57%
26.51
19.88
33.35%
25.07
26.50
-5.40%
25.01
25.45
-1.73%
Expenses
26.95
27.67
-2.60%
26.31
20.05
31.22%
24.87
24.88
-0.04%
25.14
25.43
-1.14%
EBITDA
0.86
1.78
-51.69%
0.20
-0.18
-
0.20
1.62
-87.65%
-0.13
0.02
-
EBIDTM
3.10%
6.05%
0.76%
-0.88%
-4.88%
-4.88%
-0.53%
0.07%
Other Income
0.43
0.12
258.33%
0.37
0.27
37.04%
0.41
0.88
-53.41%
0.25
1.01
-75.25%
Interest
0.52
0.25
108.00%
0.53
0.42
26.19%
0.49
1.07
-54.21%
0.41
0.39
5.13%
Depreciation
1.15
1.13
1.77%
1.16
1.19
-2.52%
1.13
1.03
9.71%
1.11
0.89
24.72%
PBT
-0.38
0.53
-
-1.11
-1.52
-
-1.02
0.41
-
-1.40
-0.26
-
Tax
0.58
0.18
222.22%
-0.06
0.26
-
0.11
0.35
-68.57%
0.26
0.57
-54.39%
PAT
-0.96
0.35
-
-1.06
-1.77
-
-1.13
0.07
-
-1.66
-0.83
-
PATM
-3.46%
1.18%
-3.99%
-8.93%
-10.84%
-10.84%
-6.65%
-3.27%
EPS
-2.18
-0.48
-
-2.62
-3.74
-
-0.96
-0.96
-
-3.55
-2.74
-

Annual Results

Standalone Figures in Rs. Crores /

Consolidated
Description
TTM
Mar 24
Mar 23
Mar 22
Mar 21
Net Sales
-
104.39
101.28
127.20
68.64
Net Sales Growth
-
3.07%
-20.38%
85.31%
 
Cost Of Goods Sold
-
51.94
39.07
50.20
27.59
Gross Profit
-
52.45
62.20
77.00
41.06
GP Margin
-
50.24%
61.41%
60.53%
59.82%
Total Expenditure
-
103.27
97.96
108.36
60.52
Power & Fuel Cost
-
11.32
12.70
8.78
5.55
% Of Sales
-
10.84%
12.54%
6.90%
8.09%
Employee Cost
-
13.94
11.73
12.51
8.71
% Of Sales
-
13.35%
11.58%
9.83%
12.69%
Manufacturing Exp.
-
18.86
28.56
29.60
12.68
% Of Sales
-
18.07%
28.20%
23.27%
18.47%
General & Admin Exp.
-
3.15
2.88
2.77
2.20
% Of Sales
-
3.02%
2.84%
2.18%
3.21%
Selling & Distn. Exp.
-
2.95
2.01
3.70
2.45
% Of Sales
-
2.83%
1.98%
2.91%
3.57%
Miscellaneous Exp.
-
1.12
0.98
0.81
1.35
% Of Sales
-
1.07%
0.97%
0.64%
1.97%
EBITDA
-
1.12
3.32
18.84
8.12
EBITDA Margin
-
1.07%
3.28%
14.81%
11.83%
Other Income
-
1.53
2.28
2.60
0.96
Interest
-
2.02
2.20
1.74
1.76
Depreciation
-
4.54
4.24
4.02
4.61
PBT
-
-3.92
-0.84
15.68
2.70
Tax
-
0.89
1.35
3.97
1.36
Tax Rate
-
-22.70%
-160.71%
25.30%
50.37%
PAT
-
-6.26
-4.75
4.98
-0.33
PAT before Minority Interest
-
-4.81
-2.19
11.72
1.35
Minority Interest
-
-1.45
-2.56
-6.74
-1.68
PAT Margin
-
-6.00%
-4.69%
3.92%
-0.48%
PAT Growth
-
-
-
-
 
EPS
-
-10.61
-8.05
8.44
-0.56

Results Balance Sheet

Standalone Figures in Rs. Crores /

Consolidated
Description
Mar 24
Mar 23
Mar 22
Mar 21
Shareholder's Funds
63.05
69.20
59.58
54.13
Share Capital
5.90
5.90
4.92
4.92
Total Reserves
57.15
63.30
54.66
49.21
Non-Current Liabilities
19.75
15.08
13.23
16.50
Secured Loans
3.08
2.32
2.69
5.53
Unsecured Loans
6.00
2.00
0.00
0.00
Long Term Provisions
0.25
0.27
0.43
0.38
Current Liabilities
37.17
27.54
33.01
33.12
Trade Payables
18.83
10.14
5.46
14.53
Other Current Liabilities
9.81
10.99
13.79
8.94
Short Term Borrowings
7.19
4.55
11.67
6.32
Short Term Provisions
1.34
1.85
2.09
3.34
Total Liabilities
161.26
152.29
144.33
136.19
Net Block
86.57
84.52
68.30
71.39
Gross Block
135.94
129.77
109.97
81.94
Accumulated Depreciation
49.38
45.25
41.67
10.55
Non Current Assets
91.45
89.04
81.42
75.15
Capital Work in Progress
0.32
0.49
9.38
0.16
Non Current Investment
0.12
0.08
0.22
1.21
Long Term Loans & Adv.
4.39
3.91
2.99
1.82
Other Non Current Assets
0.06
0.05
0.53
0.56
Current Assets
69.80
63.25
62.91
61.04
Current Investments
2.81
0.00
0.00
0.75
Inventories
33.80
31.32
23.84
27.47
Sundry Debtors
19.89
19.87
13.55
16.61
Cash & Bank
2.23
4.37
8.67
6.22
Other Current Assets
11.06
0.88
3.84
8.59
Short Term Loans & Adv.
10.04
6.81
13.00
1.40
Net Current Assets
32.63
35.71
29.90
27.92
Total Assets
161.25
152.29
144.33
136.19

Cash Flow

Standalone Figures in Rs. Crores /

Consolidated
Description
Mar 24
Mar 23
Mar 22
Mar 21
Cash From Operating Activity
0.84
-8.62
18.50
0.00
PBT
-3.92
-0.84
15.69
0.00
Adjustment
5.79
5.65
5.21
0.00
Changes in Working Capital
0.74
-10.96
3.23
0.00
Cash after chg. in Working capital
2.62
-6.15
24.13
0.00
Interest Paid
0.00
0.00
0.00
0.00
Tax Paid
-1.78
-2.47
-5.63
0.00
Other Direct Exp. Paid
0.00
0.00
0.00
0.00
Extra & Other Items
0.00
0.00
0.00
0.00
Cash From Investing Activity
-6.89
1.25
-21.79
0.00
Net Fixed Assets
-1.94
-3.46
-9.83
Net Investments
-0.04
0.03
1.11
Others
-4.91
4.68
-13.07
Cash from Financing Activity
5.74
5.78
0.33
0.00
Net Cash Inflow / Outflow
-0.31
-1.59
-2.96
0.00
Opening Cash & Equivalents
0.72
2.31
5.27
0.00
Closing Cash & Equivalent
0.41
0.72
2.31
0.00

Financial Ratios

Standalone /

Consolidated
Description
Mar 24
Mar 23
Mar 22
Mar 21
Book Value (Rs.)
106.85
117.28
121.17
105.62
ROA
-3.07%
-1.48%
8.35%
0.99%
ROE
-7.28%
-3.40%
20.61%
2.49%
ROCE
-2.36%
1.72%
24.00%
6.53%
Fixed Asset Turnover
0.79
0.84
1.33
0.84
Receivable days
69.51
60.23
43.28
88.31
Inventory Days
113.86
99.41
73.62
146.06
Payable days
101.77
72.86
72.68
192.25
Cash Conversion Cycle
81.60
86.77
44.22
42.12
Total Debt/Equity
0.28
0.17
0.29
0.26
Interest Cover
-0.94
0.62
10.03
2.53

News Update:


  • Makers Laboratories - Quarterly Results
    23rd May 2024, 13:14 PM

    Read More

Source: www.accordfintech.com | DISCLAIMER: Information is provided " as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.